AMPIO PHARMACEUTICALS INC (AMPE) Stock Price, Forecast & Analysis
NYSEARCA:AMPE • US03209T3077
AMPE Key Statistics, Chart & Performance
The current stock price of AMPE is 0.62 USD. In the past month the price decreased by -62.2%. In the past year, price decreased by -84.61%.
AMPE Technical Analysis
AMPE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AMPE. The financial health of AMPE is average, but there are quite some concerns on its profitability.
AMPE Financial Highlights
Over the last trailing twelve months AMPE reported a non-GAAP Earnings per Share(EPS) of -11.13. The EPS increased by 48.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -150.51% | ||
| ROE | -256.93% | ||
| Debt/Equity | 0 |
AMPE Forecast & Estimates
6 analysts have analysed AMPE and the average price target is 2.04 USD. This implies a price increase of 229.03% is expected in the next year compared to the current price of 0.62.
AMPE Ownership
AMPE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 31.05 | 985.228B | ||
| JNJ | JOHNSON & JOHNSON | 21.14 | 593.362B | ||
| MRK | MERCK & CO. INC. | 22.9 | 307.597B | ||
| PFE | PFIZER INC | 9.04 | 154.31B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 10.12 | 125.402B | ||
| ZTS | ZOETIS INC | 18.73 | 56.699B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.75 | 26.207B | ||
| VTRS | VIATRIS INC | 6.35 | 18.503B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 25.23 | 13.107B | ||
| AXSM | AXSOME THERAPEUTICS INC | 207.52 | 8.567B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AMPE
Company Profile
Ampio Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Englewood, Colorado and currently employs 8 full-time employees. The company went IPO on 2011-05-19. Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The firm is focused on the preclinical development of AR-300, and is conducting studies to evaluate the efficacy of AR-300 in osteoarthritis-related pain. The firm is primarily targeting the clinical development of AR-300 for the treatment of osteoarthritis of the knee (OAK). AR-300 is a small-molecule formulation that has demonstrated anti-inflammatory properties in vitro and protection of cartilage in preclinical rat meniscal tear studies.
Company Info
AMPIO PHARMACEUTICALS INC
9800 Mount Pyramid Court, Suite 400
Englewood COLORADO 80112 US
CEO: Michael Macaluso
Employees: 8
Phone: 17204376500
AMPIO PHARMACEUTICALS INC / AMPE FAQ
What does AMPIO PHARMACEUTICALS INC do?
Ampio Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Englewood, Colorado and currently employs 8 full-time employees. The company went IPO on 2011-05-19. Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The firm is focused on the preclinical development of AR-300, and is conducting studies to evaluate the efficacy of AR-300 in osteoarthritis-related pain. The firm is primarily targeting the clinical development of AR-300 for the treatment of osteoarthritis of the knee (OAK). AR-300 is a small-molecule formulation that has demonstrated anti-inflammatory properties in vitro and protection of cartilage in preclinical rat meniscal tear studies.
What is the current price of AMPE stock?
The current stock price of AMPE is 0.62 USD. The price decreased by -12.91% in the last trading session.
What is the dividend status of AMPIO PHARMACEUTICALS INC?
AMPE does not pay a dividend.
What is the ChartMill rating of AMPIO PHARMACEUTICALS INC stock?
AMPE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What sector and industry does AMPIO PHARMACEUTICALS INC belong to?
AMPIO PHARMACEUTICALS INC (AMPE) operates in the Health Care sector and the Pharmaceuticals industry.
What is AMPIO PHARMACEUTICALS INC worth?
AMPIO PHARMACEUTICALS INC (AMPE) has a market capitalization of 514.60K USD. This makes AMPE a Nano Cap stock.
Can you provide the upcoming earnings date for AMPIO PHARMACEUTICALS INC?
AMPIO PHARMACEUTICALS INC (AMPE) will report earnings on 2024-05-06, after the market close.